Laserfiche WebLink
right to access or use a niyportion or all of the Evidence.com Services immediately upon notice, <br />in accordance with the following: <br />8.1. The Termination provisions of the Master Service Agreement apply; <br />8.2. The Agency or an end user's use of or registration for the Evidence.com Services (I) <br />poses a security risk to the Evidence.com Services or any third party, (H) may adversely <br />impact the Evidence.com Services or the systems or content of any other customer, <br />(ifl) may subject Axon, Axon's affiliates, or any third party to liability, or (iv) may be <br />fraudulent; <br />8.3. If Axon suspends the right to access or use any portion, or all of the Evidence.com <br />Services, the Agency remains responsible for all fees and charges incurred through <br />the date of suspension without any credits for any period of suspension. Axon, will not <br />delete any of Agency Content on Evidence.com as a result of a suspension, except as <br />specified elsewhere in this Agreement. <br />9 Software Services Warranty. Axon warrants that the Evidence.com Services will not infringe <br />or misappropriate any patent, copyright, trademark, or trade secret rights of any third party. <br />Axon disclaims any warranties or responsibility for data corruption or errors before the data <br />is uploaded to the Evidence.com Services, <br />10 License Restrictions. Neither the Agency nor any Agency end users (including, without <br />limitation, employees, contractors, agents, officers, volunteers, and directors), may, or may <br />attempt to: (a) permit any third party to access the Evidence.com Services, except as permitted <br />in this Agreement; (b) modify, alter, tamiper with, repair, or otherwise create derivative works <br />of any of the Evidence.com Services; (c) reverse, engineer, disassemble, or clecompile the <br />Evidence.com Services or apply any other process or procedure to derive the source code of <br />any software iincluded in the Evidence.com Services, or allow any others to do the same; (d) <br />access or use the Evidence.com Services with the intent to gain unauthorized access, avoid <br />incurring fees or exceeding usage limits or quotas; (e) copy the Evidence.com Services in whole <br />or part, except as expressly permitted in this Agreement; (f) use trade secret information <br />contained in the Evidence.com Services, except as expressly permitted in this Agreement; (g) <br />resell, rent, loan, or sublicense the Evidence.com Services; N access the Evidence.com <br />Services in order to build a competitive product or service or copy any features, functions, or <br />graphics of the Evidenice.com Services; (i) remove, alter, or obscure any confidentiality or <br />proprietary rights notices (including copyright and trademark notices) of Axon's or Axon"s <br />licensors on or within the Evidence.com Services or any copies of the Evidenice.com Services; <br />or 0) use the Evidence.com Services to store or transmit infringing, libelous, or otherwise <br />unlawful or tortious material, to store or transmit material in violation of third party privacy <br />rights, or to store or transmit malicious code. All licenses granted in this Agreement are <br />conditional on continued compliance this Agreement, andl will immediately and automatically <br />terminate if the Agency does not comply with any term or condition of this Agreement. The <br />Agency may only use Axon's trademarks in accordance with the Axon Trademark Use <br />Guidelines (located at www.axon,_cgm). <br />11 After Termination. Axon will not delete any Agency Content as a result of a termination <br />during a period of 90 days following termination. During this 90-clay period the Agency may <br />retrieve Agency Content only if all amounts due have been paid (there will be no application <br />functionality of the Evidence.com Services during this 90-day period other than the ability to <br />Tlfle. Ma,lei SaMces and Purchaflng Agieement beTween Axon and Agency Page 10 of 31 <br />Dep."nwf: Sarae Cawamar Smka <br />R.1 ... a 0.1.. 6JIN2017 <br />